Fourth Annual Circulating Tumor Cells

Circulating tumor cells (CTC) remain one of the most promising areas of cancer research for guiding patient treatment and predicting cancer progression. Substantial progress is being made on technologies for the detection, characterization and analysis of CTCs. However, the biology of CTCs needs to be better understood in order for biomarkers to be identified and utilized properly. This conference will address the new evidence regarding cancer cell types and tumor progression. Additionally, case studies will showcase how engineering improvements can be applied directly to clinical care and companion diagnostics.